ClinicalTrials.Veeva
Menu

Find clinical trials for COVID-19 in Hanyang, Seoul

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Coronavirus Infections
Infections
Post-Acute COVID-19 Syndrome
Human Influenza
Pneumonia
Virus Diseases
Communicable Diseases

COVID-19 trials near Hanyang, Seoul, KOR:

A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised

IV compared to remdesivir IV alone for the treatment of symptomatic COVID-19 in severely immunocompromised adult participants who a...

Enrolling
COVID-19 Infection
Drug: remdesivir
Drug: placebo for ibuzatrelvir

Phase 3

Pfizer
Pfizer

Seoul, Seoul-teukbyeolsi [seoul], South Korea and 61 other locations

The immunogenicity and safety of AdCLD-CoV19-1 OMI (5.0x10\^10 VP (0.5 mL)/dose/Vial) administered as a booster in healthy adults aged 19 years old a...

Active, not recruiting
COVID-19
Vaccines
Biological: Comirnaty Bivalent 0.1mg/mL (tozinameran and riltozinameran)
Biological: AdCLD-CoV19-1 OMI

Phase 3

Cellid

Seoul, Korea, Republic of and 16 other locations

legal age for adult in each country) with confirmed mild or moderate COVID-19 tested positive with a real time reverse transcriptio...

Enrolling
COVID-19
Drug: ES16001 80 mg
Drug: ES16001 40 mg

Phase 2, Phase 3

Genencell

Seoul, Korea, Republic of and 2 other locations

Parallel-treatment Group, Adaptive Design, Multi-center, Phase 2b/3 Trial to Evaluate Efficacy and Safety of NuSepin® Intravenous Infusion in COVID...

Enrolling
COVID-19 Pneumonia
Drug: Placebo
Drug: NuSepin® 0.2 mg/kg

Phase 2, Phase 3

Shaperon

Incheon, Namdong-gu, Korea, Republic of

seek to enroll immunocompromised patients with Lower Tract parainfluenza infection.It also contains a sub-study to enroll patients with severe COVID...

Enrolling
COVID-19
Parainfluenza
Drug: DAS181 COVID-19
Drug: DAS181

Phase 3

Ansun Biopharma

Seoul, Gyeonggi-do, Korea, Republic of and 66 other locations

The purpose of the study is to evaluate the immunogenicity, reactogenicity, and safety of mRNA-1083 in adults 50 years of age and older in participat...

Active, not recruiting
COVID-19
Influenza
Biological: Licensed Influenza Vaccine
Biological: mRNA-1083

Phase 3

Moderna
Moderna

Seoul, South Korea and 44 other locations

The purpose of the study is to evaluate whether ibuzatrelvir is effective and safe in adults and adolescents with COVID-19 who do n...

Enrolling
COVID-19 SARS-CoV-2 Infection
Drug: placebo
Drug: ibuzatrelvir

Phase 3

Pfizer
Pfizer

Seoul, Seoul-teukbyeolsi [seoul], South Korea and 208 other locations

Researchers are looking for other ways to prevent severe illness from COVID-19. COVID-19 is a virus that most oft-...

Enrolling
Coronavirus Disease (COVID-19)
Drug: Placebo
Drug: Molnupiravir

Phase 3

Merck Sharp & Dohme (MSD)
Merck Sharp & Dohme (MSD)

Seoul, South Korea and 205 other locations

This study is to evaluate the safety, reactogenicity, and immunogenicity of the QTP104 vaccine against SARS-CoV-2 infection in healthy adults.

Active, not recruiting
COVID-19
SARS-CoV-2
Biological: QTP104 1ug
Biological: QTP104 5ug

Phase 1

Quratis

Seoul, Korea, Republic of and 1 other location

The purpose of this study is to evaluate the effect of tozorakimab, as an add-on to SoC in patients with viral lung infection requiring supplemental...

Enrolling
Viral Lung Infection and Acute Respiratory Failure
Drug: Tozorakimab
Drug: Placebo

Phase 3

AstraZeneca
AstraZeneca

Seoul, South Korea and 446 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems